View Older Stories View More Recent Stories

Nov 10, 2025 04:04PM Capricor Therapeutics (CAPR) Reports In-Line Q3 EPS, offers outlook
Nov 3, 2025 09:15AM Capricor Therapeutics publishes study on Deramiocel mechanism
Sep 25, 2025 10:44AM Options with decreasing option implied volatility: CAPR FDX WBD ACN MU LEN
Sep 25, 2025 07:15AM Capricor receives FDA clarity on Deramiocel approval path for DMD
Sep 18, 2025 05:08AM Jones Trading Reiterates Buy Rating on Capricor Therapeutics (CAPR)
Sep 12, 2025 06:46AM H.C. Wainwright Reiterates Buy Rating on Capricor Therapeutics (CAPR)
Sep 9, 2025 09:23AM Capricor responds to FDA posting of Deramiocel rejection letter
Aug 19, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on Capricor Therapeutics (CAPR)
Aug 11, 2025 04:35PM Capricor Therapeutics (CAPR) Misses Q2 EPS by 9c
Aug 8, 2025 08:30AM Capricor schedules FDA meeting on Deramiocel regulatory path
Jul 22, 2025 06:44AM Oppenheimer Reiterates Outperform Rating on Capricor Therapeutics (CAPR)
Jul 20, 2025 04:00PM CAPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jul 20, 2025 10:52AM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Capricor Therapeutics
Jul 18, 2025 01:43PM CAPR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Capricor Therapeutics, Inc. Investors
Jul 14, 2025 06:58AM Capricor Therapeutics (CAPR) PT Lowered to $24 at H.C. Wainwright
Jul 14, 2025 04:58AM Capricor Therapeutics (CAPR) August 15 calls and September 7.5 puts active
Jul 11, 2025 06:30AM Capricor receives FDA rejection for Duchenne muscular dystrophy treatment
Jun 26, 2025 02:13AM B.Riley Starts Capricor Therapeutics (CAPR) at Buy
Jun 24, 2025 01:08PM Roth/MKM Comments on Capricor Therapeutics (CAPR)
Jun 24, 2025 12:29PM H.C. Wainwright said 'Ignore the Noise' on Capricor Therapeutics (CAPR) and Buy
Jun 24, 2025 10:44AM US FDA Actively Reevaluating Whether to Proceed with the Advisory Committee Meeting for Capricor Cell Therapy - Reuters
Jun 24, 2025 09:01AM Capricor Therapeutics (CAPR) Provides Regulatory Update on Deramiocel BLA for Duchenne Muscular Dystrophy
Jun 24, 2025 06:46AM Cantor Fitzgerald Reiterates Overweight Rating on Capricor Therapeutics (CAPR)
Jun 23, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on Capricor Therapeutics (CAPR)
Jun 23, 2025 04:47AM Capricor Therapeutics (CAPR) call put ratio 1 call to 1.3 puts on 37K contracts amid wide price movement
Jun 23, 2025 04:45AM Capricor Therapeutics (CAPR) PT Lowered to $22 at Oppenheimer
Jun 20, 2025 09:25AM Capricor Therapeutics (CAPR) Announces Positive 4-Year Data from HOPE-2 Open-Label Extension Study of Deramiocel in Duchenne Muscular Dystrophy
Jun 17, 2025 09:01AM Capricor Therapeutics (CAPR) Announces Orphan Drug Designation for Becker Muscular Dystrophy and Regulatory Progress for Duchenne Muscular Dystrophy Program
Jun 16, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on Capricor Therapeutics (CAPR)
Jun 13, 2025 11:28AM H.C. Wainwright Reiterates Buy Rating on Capricor Therapeutics (CAPR); 'Calm Down People'
Jun 13, 2025 10:40AM Oppenheimer weighs in on Capricor Therapeutics (CAPR) following FDA letter and CEO meeting
Jun 11, 2025 01:03PM Capricor Therapeutics (CAPR) visibility 'increased' following latest update - Oppenheimer
Jun 11, 2025 09:25AM Capricor Therapeutics (CAPR) Announces Key Regulatory Updates for its Duchenne Muscular Dystrophy Program
May 20, 2025 02:37AM Roth/MKM Starts Capricor Therapeutics (CAPR) at Buy
May 13, 2025 04:06PM Capricor Therapeutics (CAPR) Misses Q1 EPS by 21c
May 13, 2025 09:01AM Capricor Therapeutics (CAPR) Appoints Michael Binks as Chief Medical Officer
May 5, 2025 08:06AM Capricor Therapeutics (CAPR) Announces Completion of Mid-Cycle Review Meeting with FDA on Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy
Mar 20, 2025 08:17AM Cantor Fitzgerald Reiterates Overweight Rating on Capricor Therapeutics (CAPR)
Mar 19, 2025 04:11PM Capricor Therapeutics (CAPR) Tops Q4 EPS by 1c
Mar 18, 2025 06:42AM H.C. Wainwright Reiterates Buy Rating on Capricor Therapeutics (CAPR)
Mar 17, 2025 09:25AM Capricor Therapeutics (CAPR) Announces Positive Data Demonstrating Long-Term Efficacy of Deramiocel
Mar 17, 2025 07:06AM Cantor Fitzgerald says 15% of biotech companies down 40% or more
Mar 5, 2025 06:48AM H.C. Wainwright Reiterates Buy Rating on Capricor Therapeutics (CAPR)
Mar 4, 2025 07:02AM Capricor Therapeutics (CAPR) Announces FDA Acceptance and Priority Review of its Biologics License Application for Deramiocel to Treat Duchenne Muscular Dystrophy
Jan 3, 2025 06:36AM H.C. Wainwright Reiterates Buy Rating on Capricor Therapeutics (CAPR)
Jan 2, 2025 09:15AM Capricor Therapeutics (CAPR) Completes Submission of Biologics License Application to the U.S. FDA for Deramiocel
Dec 5, 2024 01:23PM Jones Trading Reiterates Buy Rating on Capricor Therapeutics (CAPR)
Dec 2, 2024 12:28PM Piper Sandler Reiterates Overweight Rating on Capricor Therapeutics (CAPR)
Nov 20, 2024 09:02AM Capricor Therapeutics (CAPR) Granted Orphan Drug and ATMP Status for Deramiocel by European Medicines Agency
Nov 18, 2024 02:45AM Jones Trading Starts Capricor Therapeutics (CAPR) at Buy
View More Recent Stories View Older Stories